Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Zero Based Budgeting targets debt by prioritizing principal payments and efficient allocations, accelerating payoff timelines.
19,225 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
Volatile markets test an investor’s nerves and resolve. The key to thriving, not just surviving, is focusing on a dis...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...
As gas prices trend higher, Costco’s fuel discounts and bulk-buying model could attract more shoppers. This practical...
A Crinetics director sells 5,000 shares as the stock dips. This guide breaks down what insider moves really mean for ...
A crypto-fueled donation story puts UK election rules under a microscope. Reform UK’s Farage claims there’s no obliga...
When mortgage markets swung on interest-rate headlines, one fund pressed deeper into PennyMac. This article explains ...
Uber reports a landmark milestone as Uber One membership tops 50 million, with members driving half of Mobility and D...
Willdan stock skyrocketing has investors buzzing as one large fund sold about $7.74 million worth of shares. This art...
A lesser-known cloud platform is delivering eye-popping gains as AI demand climbs. Discover why this stock crushing N...
Figure Technology Solutions delivered a powerful first quarter, as blockchain lending activity surged and revenue nea...